Document Detail


Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
MedLine Citation:
PMID:  23331969     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The global impact of the 2009 influenza A(H1N1) pandemic (H1N1pdm) is not well understood. OBJECTIVES: We estimate overall and age-specific prevalence of cross-reactive antibodies to H1N1pdm virus and rates of H1N1pdm infection during the first year of the pandemic using data from published and unpublished H1N1pdm seroepidemiological studies. METHODS: Primary aggregate H1N1pdm serologic data from each study were stratified in standardized age groups and evaluated based on when sera were collected in relation to national or subnational peak H1N1pdm activity. Seropositivity was assessed using well-described and standardized hemagglutination inhibition (HI titers ≥32 or ≥40) and microneutralization (MN ≥ 40) laboratory assays. The prevalence of cross-reactive antibodies to the H1N1pdm virus was estimated for studies using sera collected prior to the start of the pandemic (between 2004 and April 2009); H1N1pdm cumulative incidence was estimated for studies in which collected both pre- and post-pandemic sera; and H1N1pdm seropositivity was calculated from studies with post-pandemic sera only (collected between December 2009-June 2010). RESULTS: Data from 27 published/unpublished studies from 19 countries/administrative regions - Australia, Canada, China, Finland, France, Germany, Hong Kong SAR, India, Iran, Italy, Japan, Netherlands, New Zealand, Norway, Reunion Island, Singapore, United Kingdom, United States, and Vietnam - were eligible for inclusion. The overall age-standardized pre-pandemic prevalence of cross-reactive antibodies was 5% (95%CI 3-7%) and varied significantly by age with the highest rates among persons ≥65 years old (14% 95%CI 8-24%). Overall age-standardized H1N1pdm cumulative incidence was 24% (95%CI 20-27%) and varied significantly by age with the highest in children 5-19 (47% 95%CI 39-55%) and 0-4 years old (36% 95%CI 30-43%). CONCLUSIONS: Our results offer unique insight into the global impact of the H1N1 pandemic and highlight the need for standardization of seroepidemiological studies and for their inclusion in pre-pandemic preparedness plans. Our results taken together with recent global pandemic respiratory-associated mortality estimates suggest that the case fatality ratio of the pandemic virus was approximately 0·02%.
Authors:
Maria D Van Kerkhove; Siddhivinayak Hirve; Artemis Koukounari; Anthony W Mounts;
Related Documents :
12883379 - Twenty-year trends of primary liver cancer incidence rates in an urban chinese population.
19427619 - Pseudoexfoliation in the reykjavik eye study: five-year incidence and changes in relate...
21861659 - Trail marking by caterpillars of the silverspot butterfly dione juno huascuma.
10219279 - The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintena...
2809119 - The role of aging in cancer incidence: an epidemiological study.
20980569 - National surveillance of fungemia in denmark (2004 to 2009).
24371819 - Analysis of the anticancer phytochemicals in andrographis paniculata nees. under salini...
22903259 - Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/derm...
20689789 - Age-related changes of ocular parameters in korean subjects.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-21
Journal Detail:
Title:  Influenza and other respiratory viruses     Volume:  -     ISSN:  1750-2659     ISO Abbreviation:  Influenza Other Respi Viruses     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101304007     Medline TA:  Influenza Other Respi Viruses     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Affiliation:
Global Influenza Programme, WHO, Geneva, Switzerland; MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low vitamin D concentrations among indigenous Argentinean children living at high altitudes.
Next Document:  A comparative study on the antioxidant activity of methanolic extracts from different parts of Morus...